Related by context. All words. (Click for frequent words.) 72 molecular biomarkers 70 molecular biomarker 70 miRNA biomarkers 69 Rosetta Genomics microRNA 69 eTag assays 69 protein biomarkers 68 DNA methylation biomarkers 68 druggable targets 68 metabolomic profiling 67 toxicogenomic 67 genomic profiling 67 Tr DNA 67 biomarkers 67 protein biomarker 67 Flow cytometry 67 DNA methylation markers 67 genomic biomarkers 67 methylation markers 67 CellPort Technologies 66 microRNA expression 66 SiMoA 66 serum biomarkers 66 immatics 66 diagnostic biomarker 66 genetic biomarkers 66 kinase profiling 66 Anticalins ® 66 biomarker 66 putative biomarkers 66 validating biomarkers 66 throughput RNAi 66 biomarker identification 66 genomic proteomic 66 comparative genomic hybridization 66 splice variants 66 metabolomic 65 NSCLC tumors 65 predictive biomarkers 65 Anticalins R 65 prognostic markers 65 tumorigenicity 65 multiplex immunoassays 65 AttoSense 65 somatic mutations 65 Corus CAD 65 mutational analysis 65 p# biomarker 65 Epigenomics proprietary 65 TLE3 65 differentially expressed proteins 65 quantitative gene expression 65 P2V TM 65 biomarker assays 65 preclinically 65 serum protein biomarkers 64 proteomic biomarkers 64 BioMAP 64 validate biomarkers 64 molecular diagnostic assay 64 COLD PCR 64 PathFinderTG 64 ALK inhibitors 64 aggregated Abeta 64 methylated DNA 64 Nanobodies ® 64 Trofex 64 vitro assay 64 quantitative PCR qPCR 64 S. maltophilia 64 proteomic analysis 64 multiplex assays 64 Adnectin 64 RNA seq 64 miRview TM mets 64 Spiegelmers 64 Curaxin 64 biomarker validation 64 PET tracers 64 diagnostic biomarkers 64 theranostic 64 anticancer therapeutics 64 SELDI 64 Ice COLD PCR 64 OnDose TM 64 comparative genomic 64 protein microarrays 64 immunochemical 64 molecular determinants 64 optical biosensors 64 tumor hypoxia 64 miRview ™ squamous 64 multiplexed assays 63 molecular abnormalities 63 Affymetrix microarray technology 63 metabonomics 63 gene loci 63 DNA methylation biomarker 63 Chronix 63 phenotyping 63 metabolomic profiles 63 microarray gene expression 63 miRNA profiling 63 Lpathomab 63 Hemopurifier TM 63 GAP #B# 63 anti CD# antibodies 63 AvalonRx R 63 biomarker assay 63 haplotyping 63 protein biomarker discovery 63 metabolite profiling 63 KRAS mutation 63 CDK inhibitors 63 Spiegelmers R 63 microRNA profiling 63 glycan microarray 63 molecular profiling 63 predictive toxicology 63 genomic biomarker 63 microRNA sequences 63 miRNA molecules 63 cellular immunotherapy 63 adrenergic regulation 63 lentiviral 63 PLAC test 63 delipidation 63 transcriptomics 63 Mammostrat 63 multiplex PCR 63 biochemical profiling 63 N glycan 63 whole exome sequencing 63 immunotherapeutic approaches 63 pharmacogenetic testing 63 A3 adenosine receptor 63 nutrigenomic 63 T SPOT.TB 63 histone deacetylase HDAC 63 DNA methylation patterns 63 engineered RAP peptides 62 epigenetic therapeutics 62 gene expression profiling 62 miRview mets 62 therapeutic monoclonal antibody 62 BioMAP ® 62 genetic loci 62 gene fusions 62 carbohydrate polymers 62 therapeutic monoclonal antibodies 62 HPV genotyping 62 splice junctions 62 peptide antigens 62 CyPath 62 florbetaben 62 HTS assay 62 prognostic biomarkers 62 miRNA expression profiles 62 bisulfite sequencing 62 differentially expressed genes 62 Septin9 biomarker 62 sDNA 62 bioluminescent imaging 62 #T# L1 62 Exome 62 genomic alterations 62 ADME properties 62 gene amplification 62 vivo potency 62 mechanistic insights 62 transcriptomic 62 tubulin inhibitor 62 APTIMA HPV 62 endophenotypes 62 Hemopurifier 62 gene expression microarrays 62 PARP inhibition 62 Infinium assay 62 genomewide 62 JAK inhibitors 62 genetic variants associated 62 splice variant 62 tumor biopsies 62 nonviral 62 immunoregulation 62 Syllego system 62 PI3K AKT 62 molecular diagnostic assays 62 #S rRNA gene 62 telomerase inhibitor 62 exome sequencing 62 preclinical efficacy 62 HER-2/neu protein 62 SELDI TOF MS 62 miRNA expression 62 biomolecular interactions 62 BioMAP ® Systems 62 Src inhibitors 62 Septin9 62 Mass spectrometry 62 multimodality imaging 62 OncoVEX 62 5 hmC 62 enzyme immunoassay EIA 62 Biomerk Tumorgrafts 62 biostatistical analysis 62 co receptor tropism 62 K ras mutations 62 haplotype map 62 ImmuKnow 62 iPSC 62 murine models 62 ACTCellerate 62 pharmacogenetic 62 miRview meso 62 ParAllele 62 flavopiridol 61 underlying molecular mechanisms 61 MAPCs 61 tumor specific antigen 61 Azedra 61 viral tropism 61 pre malignant lesions 61 BACcel 61 pharmacodynamic markers 61 immunofluorescent 61 ENMD # 61 glycopeptides 61 Septin 9 61 kidney urologic 61 mTOR inhibition 61 quantitative proteomics 61 MicroRNA 61 CobaCyte 61 hESC derived cardiomyocytes 61 Tarvacin TM 61 antisense inhibitors 61 Bayesian statistical 61 antiangiogenic agents 61 LNA TM 61 biologic pathways 61 Sphingomab 61 ELISpot 61 vascular disrupting agents 61 LungExpress Dx 61 multiplex assay 61 #beta HSD 1 61 genomic microarray 61 Western Blotting 61 CellCiphr 61 ChIP chip 61 proteomes 61 MUC1 * 61 phage display technology 61 differential gene expression 61 causal variants 61 causative mutations 61 Genpathway 61 Symadex 61 novel immunotherapeutic 61 pathogenic mechanisms 61 immunohistochemical analysis 61 VeraTag 61 transrenal DNA 61 percutaneous biopsy 61 bispecific antibody 61 bioinformatic approaches 61 nCounter 61 transcriptomes 61 accurate quantitation 61 humanized monoclonal antibodies 61 chromatin immunoprecipitation ChIP 61 adipose derived regenerative 61 tumor subtypes 61 VeraCode 61 RT qPCR 61 phage display libraries 61 Molecular imaging 61 humanized mouse 61 cMET 61 DCVax R 61 virulence genes 61 biologic pathway 61 single molecule sequencing 61 TMPRSS2 ERG 61 Sanger sequencing 61 molecular cytogenetic 61 CXCR7 61 multi analyte 61 Angiolix 61 NEUGENE R 61 KineMed 61 rxRNA 61 MultiGEN 61 M. pneumoniae 61 #S rRNA 61 transcriptome sequencing 61 NuroPro ® 61 toxicogenomics 61 Illumina genotyping 61 JAK3 61 Dyax phage display 61 KineMarker TM 61 OncotypeDX 61 PIK3CA 61 aCGH 61 OMP #M# 61 Affibody ® molecules 61 multicenter trials 61 Theranostics 61 Dr. Rafii 61 VeraTag assays 60 RayBiotech 60 STK# [002] 60 Mass Spectrometry MS 60 ChIP seq 60 quantitate 60 miRview ™ mets 60 Quanterix 60 AlloMap testing 60 DiLA2 60 anti CD3 60 gene expression microarray 60 MDx tests 60 mimetic compounds 60 viral isolates 60 mechanistic insight 60 MET amplification 60 Chemetics R 60 transgenic mouse models 60 genetic aberrations 60 HLA DQ2 60 TMPRSS2 ERG fusion 60 optimal dosing regimens 60 novel peptide 60 massively parallel sequencing 60 immunohistochemical 60 HAAH 60 RECAF TM 60 Clinical Validation 60 molecular pathogenesis 60 NEUGENE 60 isoform selective 60 multiparametric 60 PCA3 gene 60 small molecule activators 60 proteomic technologies 60 PROCHYMAL 60 NADiA 60 autism susceptibility genes 60 Power3 Medical 60 BRAF inhibitors 60 xTAG RVP 60 epitope mapping 60 trastuzumab DM1 T DM1 60 cDNA microarray 60 DNA methyltransferases 60 POTELLIGENT ® 60 breast cancer subtypes 60 Nanobodies 60 BACcel ™ system 60 Protein Expression 60 TLR9 agonists 60 neratinib 60 HepDirect prodrug 60 transfection reagents 60 Locked Nucleic Acid LNA 60 protein quantitation 60 hypoxic tumors 60 qRT PCR 60 SurroMed 60 HDL Selective Delipidation 60 regenerative medicine therapies 60 ColoMarker 60 HemoGenix 60 serologic tests 60 AlloMap 60 PCA3 60 Invader chemistry 60 glycan structures 60 zebrafish larvae 60 modifier genes 60 TLR antagonists 60 biopsied tissue 60 FTIs 60 VSELs 60 ZFN 60 TriGrid 60 telomerase activators 60 Fc gamma receptor 60 immunochemical fecal occult 60 endoglin 60 Curaxin CBLC# 60 biochemical assays 60 vitro assays 60 extramedullary 60 MALDI-TOF/TOF 60 gene expression assays 60 MMP inhibitors 60 therapeutic regimens 60 microwell plate 60 metabolite identification 60 methylation patterns 60 NPRL2 60 posttranslational modifications 60 Onconase 60 CHEMSAS ® 60 miRNA sequences 60 PSMA ADC 60 Metamark 60 noninvasive imaging 60 siRNA knockdown 60 Cytolin R 60 GeneSightRx 60 immunoregulatory 60 JAK2 inhibitors 60 NPM1 60 AMPK activators 60 Nucleic acid 60 KinomeScan 60 CTAP# Capsules 60 immune modulating 60 colorectal tumor 60 Ciphergen 60 CDX2 60 epithelial tumors 60 susceptibility loci 60 mRNA sequences 60 TaqMan 60 LEAPS TM 60 ALTTO 60 biologic therapeutics 60 Sequence Capture 60 aptamer therapeutics 60 delafloxacin 60 CBAS TM 60 Affibody 60 Tem PCR 60 XenoTech 60 anti angiogenic drugs 60 deCODE ProstateCancer TM 60 MassARRAY platform 60 targeting CD# 60 Nucleic acids 60 synthetic lethality 60 Oncotype DX colon cancer 60 BeadArray 60 PreGen Plus 60 ETBs 60 VeriStrat 60 intracellular signaling pathways 60 EGIR 60 biomarker discovery validation 60 pharmacophore 60 HCV protease inhibitors 60 rxRNA compounds 60 Sanger Sequencing 60 epigenetic regulation 60 proton MR spectroscopy 60 EGFR TKIs 60 recombinant antibodies 60 PCR Polymerase Chain Reaction 60 whole genome genotyping 59 Biodesix 59 Immunohistochemistry 59 EGFR HER 59 monoclonal antibody therapeutics 59 ADME Tox 59 RRM1 59 recombinants 59 antitumoral 59 carbohydrate compounds 59 Tß4 59 Isis antisense 59 Activity Assay 59 ESBA# 59 HybSelect 59 Pulmotype 59 immunomodulatory properties 59 radiation dosimetry 59 interactome 59 adipose tissue derived 59 LNP formulations 59 transcriptome analysis 59 antiangiogenic therapy 59 biomarker discovery 59 Vaxfectin TM 59 molecular subtypes 59 OGeS 59 noninvasive prenatal tests 59 Apobec3 59 ColonSentry ™ 59 antiviral compounds 59 protein electrophoresis 59 tropism assay 59 Microarray analysis 59 Sequencing Systems 59 bioinformatic analysis 59 pharmacodynamic biomarkers 59 Hemopurifier ® 59 cell lysate 59 proteomic analyzes 59 galectin 3 59 reverse vaccinology 59 exosome 59 Corgentin 59 ChemoFx ® 59 protein antigens 59 microRNA miRNA 59 Mutation Analysis 59 shRNA libraries 59 please visit www.metabolon.com 59 Cologuard 59 p# INK4a 59 HERmark assay 59 penetrating peptides 59 busulfan 59 OTCBB PWRM.OB 59 siRNA therapeutics 59 virosome 59 proliferative disorders 59 gene expression biomarkers 59 siRNA conjugates 59 quantitative PCR 59 OVA1 ® 59 Western blotting 59 Immunotherapeutic 59 chemoresistant 59 pretargeting 59 Optivia Biotechnology 59 lentiviral vectors 59 granzyme B 59 prognostic biomarker 59 PROLARIS 59 quantitative cytology 59 sd rxRNA compounds 59 HistoRx AQUA 59 genotypic 59 BHT DNA 59 siRNA duplexes 59 SGLT Inhibitors 59 SNP genotyping 59 HuCNS SC ® 59 Metabolomic 59 nanoviricides 59 antibody arrays 59 SureSelect 59 therapeutic radiopharmaceuticals 59 nanoprobe 59 aT cell 59 virotherapy 59 LungExpress Dx TM 59 bioinformatic analyzes 59 K RAS 59 Wechsler Reya 59 PluriCells TM 59 prognostically 59 Tarvacin 59 HIF PH inhibitors 59 PITX2 59 BSGI MBI 59 malaria parasite genome 59 RNAi therapeutic platform 59 glial tumors 59 multicenter Phase II 59 NOD mouse 59 molecular mimicry 59 BC SeraPro 59 Systemic Delivery 59 ChIP Seq 59 HemeScan test 59 Galectin 3 59 differentiate squamous 59 Pepscan 59 MammaPrint ® 59 CyPath ® 59 telomerase activation 59 prognostic marker 59 radezolid 59 SELDI TOF 59 NEDD9 59 Hair follicle 59 microbial genome sequencing 59 radionuclide therapy 59 biased ligands 59 antagomirs 59 CD# ligand 59 sequenced genomes 59 protein biochip 59 cytotoxicity assays 59 tissue microarrays 59 Panzem 59 tkRNAi 59 vivo validation 59 miRNA expression patterns 59 aptamers 59 Neuradiab 59 Array CGH 59 ReCyte 59 BACcelr8r TM 59 genomic markers 59 sarcosine 59 T#I [002] 59 shRNAs 59 nucleic acid isolation 59 Clusterin 59 OvaRex MAb 59 Arabidopsis genes 59 visit www.genenews.com 59 TÎ ² 4 59 staphylococcal vaccine 59 ELISA assays 59 mTOR inhibitors 59 transcutaneous immunization TCI 59 vivo assays 59 molecularly targeted therapy 59 folate receptor 59 CA9 SCAN 59 Infectech 59 PCR assay 59 FDG PET imaging 59 kinase inhibition 59 miRs 59 DEAR1 59 diagnostic prognostic 59 RECAF tm 59 exome capture 59 replicon 59 HERmark 59 kinome 59 predictive biomarker 59 Gene Ontology terms 59 RNAi therapeutic targeting 59 hERG 59 SmartChip System 59 sCJD 59 FluChip 59 ResponseDX Lung TM 59 Cervista HPV HR 59 StemEx R 59 AQUA ® 59 Virulizin ® 59 HeliScope Sequencer 59 human hepatocytes 59 Getzenberg 59 bacterial genomes 59 PLX cells 59 VerifyNow P#Y# 59 histone modifications 59 Genotypic 59 molecular assays 59 HLA markers 59 Affymetrix GeneChip 59 OvaRex R 59 immunological responses 59 miRview squamous 59 targeted resequencing 59 microarray experiments 59 radiolabeled TM# 59 silico prediction 59 oligonucleotide microarray 59 MaxCyte STX 59 oral gallium 59 Oncotype 59 bNAbs 59 qNPA 59 Agilent microarrays 59 NovaBay Aganocide compounds 59 OnDose 59 custirsen sodium 59 miRNA assays 59 BRAF V#E mutation 59 pharmacologic intervention 59 Febit 59 XmAb# 59 oligonucleotide microarrays 59 novel peptides 59 Confocal microscopy 59 MammaPrint R 59 transrectal ultrasound guided 59 cynomolgus macaques 59 cancer immunotherapies 59 CellOptics platform 59 CellSearch ™ 59 MenSCs 59 synthetic peptides 59 CYT# potent vascular disrupting 59 JAK2 inhibitor 58 proteomic 58 LJ# [002] 58 PCR Arrays 58 HSP# inhibitors 58 eIF 4E 58 drugable targets 58 PKCi 58 SpliceArray 58 CINtec R 58 Epidermal Growth Factor Receptor 58 antisense oligonucleotides 58 vimentin 58 oncolytic viruses 58 thymidylate synthase TS 58 non coding RNA 58 DNA microarray 58 HDAC inhibition 58 Squalamine 58 DsiRNA 58 genomic loci 58 pharmacogenomic tests 58 ChemoFx 58 blood serum biomarkers 58 lymphoid tumors 58 human pluripotent stem 58 CanAg 58 LungAlert TM 58 Tesmilifene 58 PROSTVAC TM 58 xMAP technology 58 miRNA therapeutics 58 ddRNAi 58 Pertuzumab 58 quantitative RT PCR 58 mtDNA mutations 58 chimeric protein 58 Li Fraumeni 58 small molecule modulators 58 monoclonals 58 chromosome aberrations 58 SuperAntibody 58 Anticalin ® 58 ProteinChip 58 proteomics bioinformatics 58 vivo molecular imaging 58 factor receptor FGFR 58 Lodamin 58 CyPath ® assay 58 Protein Kinase C 58 enterotypes 58 Therapeutic antibodies 58 HCV replication 58 FGFs 58 WavSTAT 58 vivo RNAi 58 GPCR targets 58 Xanafide 58 chemosensitivity 58 protein translocation 58 Optical coherence tomography 58 pyrosequencing 58 BRAF mutation 58 VitiGam 58 previously undescribed 58 miRview ® 58 isotype 58 NuroPro PD 58 FISH fluorescence 58 BrachySil TM 58 CGEMS 58 KRAS variant 58 microbiomes 58 Novavax VLP vaccine 58 missense mutations 58 immunohistochemistry IHC 58 EarlyCDT Lung 58 novel immunotherapies 58 antiproliferative effects 58 Factor VIIa 58 inhibit metastasis 58 Guava EasyCD4 58 FullTerm 58 FlexmiR 58 metastatic neuroendocrine tumors 58 DGAT1 inhibitors 58 Aureon 58 previously uncharacterized 58 adenoviral 58 FFPE tissues 58 PDE# inhibitors 58 MVA BN R 58 ACTCellerate ™ 58 PhG alpha 1 58 molecularly targeted therapies 58 CCR1 58 Cardiotoxicity 58 molecular markers 58 Odyssey Thera 58 pharmacological chaperone 58 NMR LipoProfile test 58 ResponseDX Colon TM 58 noncoding RNAs 58 Smac mimetics 58 novel therapeutic antibodies 58 Source MDx 58 Stapled Peptide 58 immunohistochemical staining 58 multigene 58 ALK mutations 58 OncoVex 58 ConclusionThis 58 primate genomes 58 insertional mutagenesis 58 methylation profiling 58 cisplatin resistant 58 immunotoxins 58 CNPs 58 P#X# 58 RNA sequences 58 OVA1 58 Fc receptor 58 ArQule Kinase Inhibitor Platform 58 throughput mass spectrometry 58 OpenArray platform 58 ReN# 58 mitochondrial DNA mtDNA 58 FLT3 58 biophotonic 58 noninvasive prenatal 58 Antigen CEA 58 targeted anticancer therapies 58 Vitaxin 58 lymphatic mapping 58 gp# protein [002] 58 microdissection 58 biospecimens 58 SynCon 58 TLR agonists 58 Vascugel 58 TAKSTA 58 bioluminescence imaging 58 Psynova 58 epigenetic therapies 58 gene methylation 58 CellSearch System 58 DXL TM 58 vivo fluorescence imaging 58 microRNA molecules 58 FSH receptor 58 product ColonSentry TM 58 Fragment Library 58 novel anticancer therapies 58 Phylomer ® 58 RQ PCR 58 Antibody Discovery 58 ResponseDX ™ 58 physiologically relevant 58 mass spectrometric 58 humanised antibody 58 CCR3 58 Ii protein 58 rxRNA TM compounds 58 monoclonal antibody mAb 58 body louse genome 58 nucleosome positioning 58 5 hydroxymethylcytosine 58 Capsulution 58 PKM2 58 nonclinical studies 58 Wnt signaling pathway 58 PhenoSense GT 58 non nucleoside HCV 58 HER2 expression 58 personalized immunotherapy 58 inhibiting angiogenesis 58 adipose derived stem cells 58 HemaQuest 58 novel VDA molecule 58 OpenArray ® 58 anticoagulant reversing agent 58 Multiple logistic regression 58 detection reagents 58 CupPrint 58 WT1 58 RNA sequencing 58 genetic polymorphisms 58 BioLeap 58 intercellular signaling 58 JVRS 58 GRNOPC1 contains 58 HER2 overexpression 58 silico modeling 58 filoviruses 58 fluoroquinolone resistance 58 Thiovir 58 favorable pharmacokinetic 58 sputum specimens 58 Zysolin TM 58 HIV tropism 58 LungSign TM 58 sd rxRNA 58 sirtuin therapeutics 58 mechanistic studies 58 infectious prion proteins 58 radioimmunotherapy RIT 58 miRagen 58 clade B 58 NNR Therapeutics 58 Anticalins 58 EGFR mutation status 58 PNA FISH TM 58 perilipin 58 solithromycin 58 combinatorial libraries 58 transcriptional profiling 58 Multi Lineage Progenitor 58 bioinformatic tools 58 miRBase 58 IMPROVE HF 58 DCE MRI 58 SNP Array #.# 58 microarray analysis 58 TRIST study 58 dimensional nanostructures 58 ELISPOT 58 Geniom 58 xMAP Technology 58 gene expression profiles 58 AtherOx 58 eGene 58 conserved sequences 58 molecularly targeted 58 peptide ligands 58 transcriptional profiles 58 multiplex biomarker 58 liposome formulations 58 skin sterol 58 NanoString 58 NPM1 mutation 58 Mechanistic studies 58 annexin 58 micro RNA 58 transcriptome profiling 58 Euroscreen 58 sCD# 58 favorable pharmacokinetic profile 58 deCODE AF TM 58 tumor antigens 58 colorectal adenocarcinoma 58 formalin fixed paraffin embedded 58 monogenic 58 vivo preclinical 58 theranostics 58 Photodynamic therapy PDT 58 anti angiogenic agents 58 gefitinib Iressa 58 pro angiogenic 58 EML4 ALK 58 OriGene 58 miRview TM 58 Metastatic colorectal cancer 58 immunofluorescence staining 58 array CGH 58 Viprovex TM 58 GIST tumors 58 myoblast 58 ELISA assay 58 Prof. Krainer 58 Reports Preclinical Data 58 2D electrophoresis 58 KRAS oncogene 58 Aurora Kinase 58 phosphorylated proteins 58 deCODE Genetics Illumina Navigenics 58 #S rDNA 58 PCA3 test 58 microRNA genes 58 serological tests 58 histone deacetylase inhibitor 58 ONCONASE R 58 GSOs 58 amyloidogenic 58 HuMax HepC 58 novel antiviral therapeutics 58 MorphoSys proprietary 58 C. difficile toxins 57 fluorescence spectroscopy 57 trastuzumab emtansine T DM1 57 sputum cytology 57 HistoScanning 57 AKIP TM 57 viral antigens 57 electrophysiological properties 57 Detect Ready MRSA 57 Dr. Bezprozvanny 57 iPS derived 57 microarray 57 biodegradable nanoparticles 57 CMV vaccine 57 pharmacogenetic tests 57 Tarvacin Anti Viral 57 TransVax tm 57 dissolving microneedles 57 Transcriptome 57 pilocytic astrocytomas 57 biophysical techniques 57 prognostic variables 57 Vaxfectin 57 OvPlex 57 nCounter Analysis System 57 hybridoma 57 PSP# [002]